Press Releases August 19, 2026 04:05 PM

Merit Medical Announces Global Operations Leadership Transition

Merit Medical appoints Sheri Lewis as EVP of Global Operations amid leadership transition

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
MMSI

Merit Medical Systems announced that Sheri Lewis will join the company as Executive Vice President of Global Operations, effective August 31, 2026, succeeding Neil Peterson who is transitioning to a Senior Advisor role before retiring. Lewis brings 30 years of experience in global operations and supply chain management, expected to support Merit’s global growth strategy.

Merit Medical Announces Global Operations Leadership Transition
MMSI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Sheri Lewis appointed EVP of Global Operations, bringing extensive experience in manufacturing, supply chain, and operational excellence.
  • Neil Peterson transitions to Senior Advisor role, concluding his 32-year tenure with Merit Medical by March 2027.
  • Leadership shift aims to strengthen Merit's global operations as it pursues long-term growth in the healthcare technology sector.

SOUTH JORDAN, Utah, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer of healthcare technology, today announced that Sheri Lewis has agreed to join Merit as Executive Vice President of Global Operations, effective August 31, 2026.

Ms. Lewis brings three decades of experience across global operations, manufacturing, and supply chain management. She previously held senior roles at SkinHealth Systems, Inc., Avantor, Medtronic, and Honeywell, leading global manufacturing, distribution, logistics, supply chain, quality, regulatory, environmental health and safety, and operational excellence functions across large, complex organizations.

"Sheri is an accomplished operations executive with a strong record of leading complex organizations and building high-performing teams," said Martha G. Aronson, Merit’s President and Chief Executive Officer. "Her experience strengthening integrated business processes, ensuring product availability, and driving global operational excellence will be important as Merit continues to scale globally and execute its long-term growth strategy."

To support continuity, Mr. Peterson will move into the role of Senior Advisor, where he will help ensure a smooth transition through March 5, 2027. At that time, Mr. Peterson will complete his service to Merit after more than 32 years with the company.

Mr. Peterson has held leadership roles across Merit’s operations and engineering functions, most recently serving as Chief Operating Officer for the past four years. Throughout his career, he has strengthened product quality, improved on-time delivery, advanced operational efficiencies, and driven cost reductions. He also helped navigate supply chain constraints, raw material shortages, and the operational challenges of the COVID-19 pandemic. Mr. Peterson has consistently shown a deep commitment to supporting employees and their well-being.

"Neil has been a dedicated and respected leader at Merit. His operational discipline, commitment to execution, and deep knowledge of our manufacturing and supply chain network have contributed meaningfully to the company’s growth and performance," added Aronson. "We are grateful for his many contributions and for the important role he has played in strengthening our global operations."

ABOUT MERIT MEDICAL

Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,500 people worldwide.

CONTACTS

PR/Media Inquiries 
Sarah Comstock

Merit Medical 
+1-801-432-2864 | sarah.comstock@merit.com 

Investor Inquiries 
Mike Piccinino, CFA, IRC 
ICR Healthcare 
+1-443-213-0509 | mike.piccinino@icrhealthcare.com


Risks

  • Potential operational disruption during leadership transition impacting manufacturing and supply chain efficiency.
  • Challenges in scaling global operations amid ongoing supply chain volatility and material shortages.
  • Execution risks associated with implementing long-term growth strategies in a competitive healthcare technology market.

More from Press Releases

Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call Sep 6, 2026 Verizon Waives Charges for Hurricane Lowell, Prepares Network in Hawai'i Sep 5, 2026 Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen Sep 4, 2026 Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Increase in August 2026 of 0.5% Compared to 2025 Sep 4, 2026 Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference Sep 4, 2026